Randomized controlled trial ยท 2022
Safety of Light Emitting Diode-Red Light on Human Skin: Two Randomized Controlled Trials. 2022.
This record summarizes category-level photobiomodulation evidence. It is not a clinical study of the rePretty Mat and should not be read as a product-specific treatment claim.
Protocol
What was reviewed or tested
633 nm LED red light delivered to forearm skin at escalating high fluences under controlled conditions.
Selected outcomes
What the record reports
- No serious adverse events were reported, while dose-limiting erythema or blistering occurred at the highest exposures.
Required reading
Limitations
- The protocol used a small treatment area and unusually high controlled fluences.
- Results cannot define the safety or dose of a different home device or body-wide routine.
Original source
Citation
Safety of Light Emitting Diode-Red Light on Human Skin: Two Randomized Controlled Trials. 2022.
Use the evidence
Related explanations
Learn pages translate the research question into plain language while preserving the same transfer limits.